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Abstract–New cationic trialkylphosphines [P(CH2NH2R){CH2N(R)CH2N(R)CH2}]+ (R = C6H5CH2 
a; 4-FC6H4CH2 b), as their Cl− (1a, 1b), SbF6− (2a, 2b) and PF6− (3a, 3b) salts, are described. The 
phosphine framework is conformational locked, in the solid state, through pairs of intramolecular 
N−H···N hydrogen-bonds which are maintained in the RuII and RhIII complexes 4 and 5. Phosphines 
1a−3b can be considered as charged variants of the well known PTA ligand. 
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Introduction 
The ability by which tertiary phosphines can be modified undoubtedly remains a major reason why this 
ligand class continues to find spectacular success in many branches of chemistry. Considerable recent 
interest has focused on the aliphatic caged tertiary phosphine 1,3,5-triaza-7-phosphaadamantane 
(hereafter abbreviated PTA) which has been shown to possess many desirable attributes including water 
solubility.1 Synthetic routes for modifying the adamantanoid framework of PTA such as 
protonation/alkylation of the tertiary nitrogen atoms or upper/lower rim functionalization have been 
reported.2,3 Consequently numerous applications of PTA and their derivatives in biomedicine,4 
coordination and organometallic chemistry4,5 and catalysis,6 especially in aqueous media, have been 
realized. One aspect of PTA not previously investigated is the ability to manipulate the nitrogen centers 
by, for example, changing the alkyl/aryl substituents yet preserve the tertiary amine character as opposed 
to quaternization3b or forming boronated species.5c One approach by which this could be accomplished 
is to envisage removal of two “upper-rim” methylene (N−CH2−N) groups from PTA thereby allowing 
different R groups on nitrogen to be incorporated. Using suitable non-covalent interactions, such as 
intramolecular H-bonding, would allow for retention of the adamantane core. As part of ongoing studies 
in our group we have recently developed highly functionalized (di)tertiary phosphines with regiospecific 
H-bonding capabilities.7 Herein a simple concept for the synthesis of novel cationic trialkylphosphines, 
with similar stereoelectronic properties to PTA, and a preliminary exploration of their late transition 
metal chemistry are reported. All new compounds have been characterized by a combination of 
spectroscopic and single crystal X-ray diffraction techniques.  
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Experimental Section 
Materials. All manipulations and reactions were carried out under aerobic conditions. 
Dichloromethane was previously distilled over CaH2, diethyl ether over sodium/benzophenone and 
tetrakis(hydroxymethyl)phosphonium chloride (THPC) was recrystallized from 2-propanol before use.8 
All other solvents and chemicals were obtained from commercial suppliers and used without further 
purification. The dinuclear metal compounds {RuCl2(η6-p-cymene)}2 and {RhCl2(η5-Cp*)}2 were 
prepared according to published procedures.9,10 
 
Instrumentation. FT−IR spectra were recorded within pressed KBr pellets over the range 4000−200 
cm−1 using a Perkin-Elmer system 2000 FT spectrometer. 1H NMR and 31P{1H} NMR spectra were 
recorded on a Bruker DPX-400 FT spectrometer with chemical shifts (δ) reported relative to external 
TMS or 85% H3PO4. Coupling constants (J) in Hz. All NMR spectra were recorded in dmso-d6 
solutions at ca. 298 K. Elemental analyzes (Perkin-Elmer 2400 CHN or Exeter Analytical, Inc. CE-440 
Elemental Analyzers) were performed by the Loughborough University Analytical Service within the 
Department of Chemistry. Mass spectra for 1a−5 were analyzed (JEOL SX102 instrument) by fast atom 
bombardment (FAB) in a positive ionization mode using a 3-nitrobenzyl alcohol (NOBA) matrix. 
Compounds 6a and 6b were analyzed (Finnigan MAT 95XP) by low-resolution FAB (LSIMS) in 
positive ionization mode using CH2Cl2 as the solvent and a NOBA matrix.  
 
Preparation of 1a. To a solution of THPC (3.83 g, 20.1 mmol) in EtOH (100%, 75 ml) was added 
dropwise C6H5CH2NH2 (8.94 g, 83.4 mmol). During the addition heat was generated and thick white 
fumes were observed. After ca. 5 min the solution became clear. The mixture was stirred for 2 h at room 
temperature (frequently some unwanted “sticky” material was formed which was separated from the 
solution by decantation) and the volume reduced on a rotary evaporator to approx. a quarter of the 
original volume. The resulting crystalline solid was filtered and dried under vacuum. Yield: 7.60 g 
 5 
(86%). Selected data: 31P{1H} NMR: −55.0 ppm. 1H NMR: 9.55 (br, NH2, 2H), 7.59−7.01 (m, arom. 
H, 15H), 4.21 (s, CH2, 2H), 3.42−3.38 (m, CH2, 8H), 3.18 (d, 2JPH 13.6, CH2, 2H), 2.65 (t, CH2, 2H) 
ppm. FT−IR: 3028 and 2781 (br, NH and CH) cm−1. FAB−MS: m/z 404 [M – Cl]. Anal. Calcd. for 
C25H31N3PCl: C, 68.24; H, 7.12; N, 9.55. Found: C, 68.25; H, 7.10; N, 9.58.  
 
Preparation of 1b. To a solution of THPC (2.85 g, 14.9 mmol) in EtOH (100%, 55 ml) was added 
dropwise 4-FC6H4CH2NH2 (7.77 g, 62.0 mmol). The mixture was stirred for 2 h at room temperature 
and the volume reduced on a rotary evaporator to approx. a quarter of the original volume. The resulting 
crystalline solid was filtered and dried under vacuum. Additional crops of 1b were obtained when the 
filtrate was allowed to stand for more than 24 h. Yield: 6.11 g (83%). Selected data: 31P{1H} NMR: 
−55.2 ppm. 1H NMR: 7.62−6.93 (m, arom. H, 12H), 4.21 (s, CH2, 2H), 3.29 (multiplicity could not 
fully be assigned due to overlap with residual solvent peaks, CH2), 3.18 (d, 2JPH 13.8, CH2, 2H), 2.67 
(t, CH2, 2H) ppm. FT−IR: 3044 and 2821 (br, NH and CH) cm−1. FAB−MS: m/z 458 [M – Cl]. Anal. 
Calcd. for C25H28F3N3PCl: C, 60.78; H, 5.73; N, 8.51. Found: C, 60.56; H, 5.58; N, 8.41.  
 
Preparation of 2a. A solution of Na(SbF6) (0.18 g, 0.69 mmol) in the minimum volume of HPLC 
grade CH3OH was added to a solution of 1a (0.20 g, 0.45 mmol) in HPLC grade CH3OH (10 ml). The 
solution was stirred at room temperature for 30 min. Concentration of the solution, under reduced 
pressure, and addition of distilled water afforded a colorless precipitate which was filtered and dried 
under vacuum. Yield: 0.28 g (97%). Selected data: 31P{1H} NMR: −55.2 ppm. 1H NMR: 9.01 (br, NH2, 
2H), 7.49−6.92 (m, arom. H, 15H), 4.22 (s, CH2, 2H), 3.57−3.41 (multiplicity could not fully be 
assigned due to overlap with residual solvent peaks, CH2), 3.10 (d, 2JPH 12, CH2, 2H), 2.66 (t, CH2, 
2H) ppm. FT−IR: 3064, 3031 and 2808 (s, NH and CH), 654 (vs, SbF) cm−1. FAB−MS: m/z 404 [M – 
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SbF6]. Anal. Calcd. for C25H31N3PSbF6·0.5H2O: C, 46.25; H, 4.98; N, 6.47. Found: C, 46.35; H, 4.80; 
N, 6.46.  
 
Preparation of 2b. A solution of Na(SbF6) (0.16 g, 0.61 mmol) in the minimum volume of HPLC 
grade CH3OH was added to a solution of 1b (0.20 g, 0.40 mmol) in HPLC grade CH3OH (10 ml). The 
solution was stirred at room temperature for 30 min. Concentration of the solution, under reduced 
pressure, and addition of distilled water afforded a colorless precipitate which was filtered and dried 
under vacuum. Yield: 0.21 g (73%). Selected data: 31P{1H} NMR: −55.0 ppm. 1H NMR: 8.95 (br, NH2, 
2H), 7.57−6.98 (m, arom. H, 12H), 4.22 (s, CH2, 2H), 3.84−3.50 (multiplicity could not fully be 
assigned due to overlap with residual solvent peaks, CH2), 3.10 (d, 2JPH 13.6, CH2, 2H), 2.67 (t, CH2, 
2H) ppm. FT−IR: 3052, 2953, 2830, 2799 and 2730 (m, NH and CH), 653 (vs, SbF) cm−1. FAB−MS: 
m/z 458 [M – SbF6]. Anal. Calcd. for C25H28N3PSbF9·0.5H2O: C, 42.70; H, 4.16; N, 5.98. Found: C, 
42.46; H, 3.90; N, 5.87.  
 
Preparation of 3a. A solution of K(PF6) (0.13 g, 0.71 mmol) in the minimum volume of HPLC grade 
CH3OH was added to a solution of 1a (0.20 g, 0.45 mmol) in HPLC grade CH3OH (10 ml). The 
solution was stirred at room temperature for 30 min. Concentration of the solution, under reduced 
pressure, and addition of distilled water afforded a colorless precipitate which was filtered and dried 
under vacuum. Yield: 0.18 g (72%). Selected data: 31P{1H} NMR: −54.6, −144.2 ppm, 1JPF 711 (PF6−). 
1H NMR: 9.02 (br, NH2, 2H), 7.49−7.01 (m, arom. H, 15H), 4.23 (s, CH2, 2H), 3.85−3.41 (multiplicity 
could not fully be assigned due to overlap with residual solvent peaks, CH2), 3.10 (d, 2JPH 14, CH2, 
2H), 2.67 (t, CH2, 2H) ppm. FT−IR: 3030 and 2809 (w, NH and CH), 842 (vs, PF) cm−1. FAB−MS: m/z 
404 [M – PF6]. Anal. Calcd. for C25H31N3P2F6: C, 54.64; H, 5.70; N, 7.65. Found: C, 55.03; H, 5.61; 
N, 7.68.  
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Preparation of 3b. A solution of K(PF6) (0.11 g, 0.60 mmol) in the minimum volume of HPLC grade 
CH3OH was added to a solution of 1b (0.20 g, 0.40 mmol) in HPLC grade CH3OH (10 ml). The 
solution was stirred at room temperature for 30 min. Concentration of the solution, under reduced 
pressure, and addition of distilled water afforded a colorless precipitate which was filtered and dried 
under vacuum. Yield: 0.20 g (83%). Selected data: 31P{1H} NMR: −54.4, −144.2 ppm, 1JPF 714 (PF6−). 
1H NMR: 9.00 (br, NH2, 2H), 7.58−6.98 (m, arom. H, 12H), 4.22 (s, CH2, 2H), 3.84−3.51 (multiplicity 
could not fully be assigned due to overlap with residual solvent peaks, CH2), 3.12 (d, 2JPH 13.6, CH2, 
2H), 2.67 (t, CH2, 2H) ppm. FT−IR: 3077, 3042, 3007, 2949, 2820 (m, NH and CH), 848 (vs, PF) cm−1. 
FAB−MS: m/z 458 [M – PF6]. Anal. Calcd. for C25H28N3P2F9·H2O: C, 48.32; H, 4.88; N, 6.76. Found: 
C, 48.21; H, 4.51; N, 6.72.  
 
Preparation of RuCl2(η6-p-cymene)(2a) (4). To a stirred solution of {RuCl2(η6-p-cymene)}2 (0.030 
g, 0.049 mmol) in CH2Cl2 (10 ml) was added 2a (0.063 g, 0.10 mmol) as a solid in one portion. The 
solution was stirred for 30 min, the volume reduced to ca. 1−2 ml under reduced pressure and Et2O (10 
ml) added. The suspension was stirred for 30 min and the solid collected on a glass sinter and dried 
under vacuum. Yield: 0.080 g (91%). Selected data: 31P{1H} NMR: 7.3 ppm. 1H NMR: 8.98 (br, NH2, 
2H), 7.53−6.99 (m, arom. H, 15H), 5.94 (dd, 3JPH 8, C6H4, 4H), 4.29 (s, CH2, 2H), 4.02 (d, 2JPH 4.8, 
CH2, 2H), 3.80−3.71 (m, CH2, 4H), 3.45 (partially obscured by solvent, CH2), 2.62 (sept, 3JPH 6.8, 
CH(CH3)2, 1H), 1.96 (CH3, 3H), 1.14 (d, 3JPH 6.8, CH(CH3)2, 6H) ppm. FT−IR: 3060 and 2967 (w, 
NH and CH), 660 (vs, SbF) cm−1. FAB−MS: m/z 710 [M – SbF6]. Anal. (bulk material) Calcd. for 
C35H45N3PSbF6RuCl2·3.5CH2Cl2: C, 37.18; H, 4.22; N, 3.38. Found: C, 37.17; H, 4.00; N, 3.24. A 
single crystal X-ray determination of 4 showed 1.67 CH2Cl2 molecules present in the crystal lattice. 
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Preparation of RhCl2(η5-Cp*)(2a) (5). To a stirred solution of {RhCl2(η5-Cp*)}2 (0.030 g, 0.050 
mmol) in CH2Cl2 (10 ml) was added 2a (0.062 g, 0.10 mmol) as a solid in one portion. The solution 
was stirred for 30 min, the volume reduced to ca. 1−2 ml under reduced pressure and Et2O (10 ml) 
added. The suspension was stirred for 30 min and the solid collected on a glass sinter and dried under 
vacuum. Yield: 0.090 g (98%). Selected data: 31P{1H} NMR: 4.6 ppm, 1JRhP 144. 1H NMR: 7.51−6.91 
(m, arom. H, 15H), 4.37 (s, CH2, 2H), 4.10 (s, CH2, 2H), 3.76 (d, 2JPH 12.4, CH2, 4H), 3.22 
(multiplicity could not fully be assigned due to overlap with residual solvent peaks, CH2), 1.67 (s, η5-
Cp*, 15H) ppm. FT−IR: 3031 (br, NH and CH), 660 (vs, SbF) cm−1. FAB−MS: m/z 712 [M – SbF6]. 
Anal. (bulk material) Calcd. for C35H46N3PSbF6RhCl2·CH2Cl2: C, 41.81; H, 4.68; N, 4.06. Found: C, 
41.46; H, 4.50; N, 4.07. A single crystal X-ray determination of 5 showed two CH2Cl2 molecules 
present in the crystal lattice. 
 
Preparation of trans-RhCl(CO)(1a)2 (6a). To a stirred solution of {RhCl(CO)2}2 (0.030 g, 0.080 
mmol) in CH2Cl2 (10 ml) was added 1a (0.14 g, 0.32 mmol) as a solid in one portion. The dark orange 
solution immediately went pale yellow and a yellow solid deposited within ca. 10 min. The suspension 
was stirred for 30 min, the volume reduced to ca. 1−2 ml under reduced pressure and Et2O (10 ml) 
added. The solid was collected on a glass sinter and dried under vacuum. Yield: 0.14 g (88%). Due to 
the extreme insolubility of 6a in both non polar and polar solvents no meaningful NMR (1H, 31P) data 
could be obtained for this compound. FT−IR: 1979 (CO) cm−1. LSI−MS: m/z 1009 [M – 2H – Cl]. Anal. 
Calcd. for C51H62N6OP2RhCl3·1.25CH2Cl2: C, 54.45; H, 5.65; N, 7.29. Found: C, 54.28; H, 5.40; N, 
7.46.  
 
Preparation of trans-RhCl(CO)(1b)2 (6b). To a stirred solution of {RhCl(CO)2}2 (0.030 g, 0.080 
mmol) in CH2Cl2 (10 ml) was added 1b (0.15 g, 0.30 mmol) as a solid in one portion. The dark orange 
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solution immediately went pale yellow and a yellow solid deposited within ca. 10 min. The suspension 
was stirred for 30 min, the volume reduced to ca. 1−2 ml under reduced pressure and Et2O (10 ml) 
added. The solid was collected on a glass sinter and dried under vacuum. Yield: 0.16 g (93%). Due to 
the extreme insolubility of 6b in both non polar and polar solvents no meaningful NMR (1H, 31P) data 
could be obtained for this compound. FT−IR: 1979 (CO) cm−1. LSI−MS: m/z 1117 [M – 2H – Cl]. Anal. 
Calcd. for C51H56N6OP2F6RhCl3·CH2Cl2: C, 50.40; H, 4.72; N, 6.78. Found: C, 50.63; H, 4.70; N, 
6.94.  
 
X-ray crystallography. Suitable crystals of 1b were obtained by allowing an ethanol filtrate, obtained 
from the reaction of THPC with 4-FC6H4CH2NH2, to stand for several days. Crystals of 2b and 3a were 
obtained upon layering a CH2Cl2 solution with petroleum ether (b.p. 40−60 °C) over several days. Slow 
diffusion of petroleum ether (b.p. 40−60 °C) into a CDCl3/CH2Cl2 solution gave X-ray quality crystals 
of 4·1.67CH2Cl2. Vapor diffusion of Et2O into a CH2Cl2 solution gave suitable crystals of 5·2CH2Cl2.  
 
Measurements for 1b, 2b, 3a and 4·1.67CH2Cl2 were made on a Bruker Apex 2 CCD diffractometer, at 
150 K, using graphite-monochromated radiation from a sealed tube Mo−Kα source (λ = 0.71073 Å). 
Diffraction data for 5·2CH2Cl2 was collected, at 153 K, using a rotating anode source and a Bruker-
Nonious Roper CCD camera. Narrow frame ω−scans were employed for 1b, 2b, 3a and 4·1.67CH2Cl2, 
φ and ω−scans were used for 5·2CH2Cl2. Intensities were corrected semi-empirically for absorption, 
based on symmetry-equivalent and repeated reflections. The structures were solved by direct methods 
(Patterson synthesis for 4·1.67CH2Cl2) and refined on F2 values for all unique data by full-matrix least-
squares. Table 1 gives further details. All non-hydrogen atoms were refined anisotropically. NH 
hydrogens for 2b, 3a and 4 had coordinates freely refined with Ueq set to 1.2Ueq of the carrier atom, 
whilst the remaining hydrogen coordinates were constrained using a riding model with Ueq set to 1.2Ueq 
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of the carrier atom (1.5Ueq for methyl hydrogen). In 4·1.67CH2Cl2, one of the CH2Cl2 molecules was 
modeled as disordered over two sets of positions. This disorder was refined with restraints on geometry 
and anisotropic displacement parameters. Major component = 66.0(3)%. In 5·2CH2Cl2, the SbF6− 
counter ion was found to be disordered over two sets of positions and was refined as above; major 
component = 80.7(5)%. Programs used were COLLECT11 or Bruker AXS APEX 212 for diffractometer 
control and DENZO13 or SAINT14 for frame integration, Bruker SHELXTL15,16 for structure solution, 
refinement and molecular graphics and local programs. Disordered molecules of CH2Cl2 (for 
5·2CH2Cl2) were modeled by the Platon Squeeze procedure.17 
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Table 1. Details of the X-ray data collections and refinements for compounds 1b, 2b, 
3a, 4·1.67CH2Cl2 and 5·2CH2Cl2. 
Compound 1b 2b 3a 4·1.67CH2Cl2 5·2CH2Cl2 
formula C25H28ClF3N3P C25H28F9N3PSb C25H31F6N3P2 C36.67H48.33Cl5.33
F6N3PRuSb 
C37H50Cl6F6N3PRhSb 
 M 493.92 694.22 549.47 1087.65 1119.13 
Cryst dimens, mm3 0.40 x 0.34 x 0.23 0.27 x 0.21 x 0.04 0.50 x 0.21 x 0.15 0.31 x 0.22 x 0.11 0.16 x 0.10 x 0.04 
Cryst morphology 
and color 
block, colorless plate, colorless block, colorless block, orange plate, orange 
Cryst syst orthorhombic triclinic orthorhombic triclinic monoclinic 
space group Ama2 P−1 Pbca P−1 P21/n 
a/Å 13.7194(15) 8.5038(12) 17.9476(5) 12.9426(5) 8.9106(3) 
b/Å 18.513(2) 8.8389(13) 15.8400(5) 14.0425(5) 14.7367(4) 
c/Å 9.5476(10) 19.082(3) 19.1365(6) 14.7175(6) 30.8857(9) 
α/(deg)  77.019(2)  65.2785(5)  
β/(deg)  78.879(2)  70.5853(5) 95.887(2) 
γ/(deg)  84.880(2)  66.5392(5)  
V/Å3 2425.0(5) 1369.8(3) 5440.3(3) 2184.23(15) 4034.3(2) 
Z 4 2 8 2 4 
µ/mm−1 0.265 1.147 0.220 1.383 1.578 
θ range/˚ 2.20−28.97 2.23−24.76 2.02−30.55 1.67−30.55 2.00−27.55 
measured reflns 10554 10538 62276 25887 47660 
independent reflns 2932 4663 8335 13047 9116 
observed reflns  
(F2 > 2σ(F2)) 
2902 4154 6759 11295 6545 
Rint 0.0216 0.0227 0.0291 0.0183 0.0658 
R1 [F2 > 2σ(F2)]a 0.0546 0.0259 0.0377 0.0377 0.0830 
wR2 [all data]b 0.1281 0.0675 0.1091 0.1033 0.2031 
largest difference 
map features/eÅ3 
0.388, −0.621 0.838, −0.759 0.408, −0.316 1.863, −1.184 1.389, −0.648 
 
a R1 = ∑||Fo| - |Fc||/∑|Fo|. b wR2 = [∑[w(Fo2 - Fc2)2]/∑[w(Fo2)2]]1/2. 
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Results and Discussion 
Commercially available tetrakis(hydroxymethyl)phosphonium chloride (THPC, [P(CH2OH)4]Cl) has 
previously been shown to react with primary aromatic amines, through a series of condensation and 
elimination steps, to give aniline based tertiary phosphines.8,18 In contrast we have found when more 
basic benzylic amines such as C6H5CH2NH2 and 4-FC6H4CH2NH2 are reacted with THPC (ca. 4:1 
ratio), crystalline cationic chloride salts 1a and 1b are obtained in high yields (typical non-optimized 
yields >80%, Scheme 1). Using this procedure we have successfully synthesized batches of 1a at the 
5−10 g scale. Anion metathesis of 1a or 1b with Na(SbF6) or K(PF6) in CH3OH at r.t. gave the 
corresponding salts 2a–3b in excellent yields (72−97%). Compounds 1a−3b have been fully 
characterized by spectroscopic and analytical methods. In particular, the 31P{1H} NMR spectra (dmso-
d6) of 1a−3b showed a single phosphorus resonance around δP –55, some 40 ppm downfield with 
respect to PTA [δP –96.2, D2O].2a At ambient temperature 1a−3b possess good solubility in CH2Cl2, 
CH3OH and dmso but were found to be insoluble in H2O. Furthermore, in the solid state 1a−3b are air 
stable, but slowly oxidize in dmso-d6 solution over ca. 24 h. 
 
Scheme 1 Preparation of salts 1a–3b.a  
 
P
+ Cl- + Cl-
R = C6H5CH2
R = 4-FC6H4CH2
1a
1b
R = C6H5CH2, X = SbF6
R = 4-FC6H4CH2, X = SbF6
R = C6H5CH2, X = PF6
R = 4-FC6H4CH2, X = PF6
2a
2b
3a
3b
(i) (ii)
HO
HO
OH
HO
+ X-
P
N
N
R
R
N
H
H
R
P
N
N
R
R
N
H
H
R
 
aKey: Reagents and conditions: (i) 4.1 equiv C6H5CH2NH2 or 4.2 equiv 4-FC6H4CH2NH2, C2H5OH 
(ii) Na(SbF6) or K(PF6), CH3OH. 
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The X-ray structures of 1b (Figure 1), 2b (Supporting Information) and 3a (Figure 2) have been 
determined. Compound 1b was found to lie across a crystallographic mirror plane that bisects the 
ammonium group of the cation and the methylene diamine bridge (mirror plane runs through 
P1/C1/N1/C2/C3/C6/F1/C8). Inspection of the intracage P−C bond lengths and P−C−N bond angles 
reveals close similarities with those of PTA.19 The C−P−C angles within the P−C−N−C−N−C ring in 
1b, 2b and 3a are in the range 97.78(5)−99.4(2)° and slightly enlarged in comparison with PTA [C−P−C 
96.1(1)°].19 The most significant structural feature observed in 1b, 2b and 3a is the presence of a pair of 
intramolecular hydrogen-bonds between N(1)−H(1A)···N(2) and N(1)−H(1B)···N(3) [1b, N(1)···N(2) 
2.915(5) Å, H(1B)···N(2) 2.27 Å, N(1)−H(1B)···N(2) 126°. 2b, N(1)···N(2) 2.804(3) Å, H(1A)···N(2) 
2.14(3) Å, N(1)−H(1A)···N(2) 138(3)° and N(1)···N(3) 2.841(3) Å, H(1B)···N(3) 2.20(3) Å, 
N(1)−H(1B)···N(3) 130(2)°. 3a, N(1)···N(2) 2.8506(13) Å, H(1A)···N(2) 2.241(15) Å, 
N(1)−H(1A)···N(2) 128.7(12)° and N(1)···N(3) 2.8234(13) Å, H(1B)···N(3) 2.154(15) Å, 
N(1)−H(1B)···N(3) 132.9(12)°]. Various additional weak intermolecular H-bonding contacts exist 
between the cations and Cl−, SbF6−  or PF6− counter ions leading to infinite 1-D chains or 2-D sheet 
structures (Supporting Information for further details). 
The single crystal data highlight three key findings regarding the N−H···N hydrogen-bonded 
framework20 in the cations of 1b, 2b and 3a, namely (i) while all synthetic reactions were performed in 
alcohol solvents (CH3OH or C2H5OH), or required water for precipitation, no disruption of the 
N−H···N intramolecular hydrogen-bonded motif was apparent under the experimental/crystallization 
conditions employed, (ii) the core structure of each cation is independent of counter anion (Cl−, SbF6− or 
PF6−) even though the potential for alternate hydrogen-bonding arrangements involving these anions is 
possible, and (iii) the absence of N−H···F−C contacts, albeit rarely observed21, shows that the three 
electronegative fluorines in the 4-position (1b and 2b) do not disrupt the N−H···N hydrogen-bonding 
array found here.  
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        (a)           (b) 
Figure 1. (a) ORTEP of the cation in 1b. Selected bond lengths (Å) and angles (deg). P(1)−C(1) 
1.841(5), P(1)−C(7) 1.847(3). P(1)−C(1)−N(1) 116.2(3), P(1)−C(7)−N(2) 113.8(2). Thermal ellipsoids 
are drawn at the 50% probability level. (b) Packing plot of 1b viewed along the c-axis showing the H-
bonded sheet pattern. 
 
             
      (a)        (b) 
Figure 2. (a) ORTEP of the cation in 3a. Selected bond lengths (Å) and angles (deg). P(1)−C(1) 
1.8490(12), P(1)−C(9) 1.8359(12), P(1)−C(10) 1.8366(13). P(1)−C(1)−N(1) 116.70(7), 
P(1)−C(9)−N(2) 114.09(7), P(1)−C(10)−N(3) 113.53(7). Thermal ellipsoids are drawn at 
the 50% probability level. (b) Packing plot of 3a viewed along the c-axis showing the 1-
D chain pattern. 
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Dyson and co-workers4h,4j have previously shown that half-sandwich organometallic RuII and RhIII 
compounds of PTA can be synthesized. In order to assess whether 2a could function as a similar P-
monodentate ligand, the piano-stool complexes 4 and 5 were prepared in high yields. Reassuringly the 
coordination chemical shifts for 4 (∆δP 62 ppm) and 5 (∆δP 60 ppm) were found to closely match those 
of RuCl2(η6-p-cymene)(PTA) (∆δP 60 ppm) and RhCl2(η5-Cp*)(PTA) (∆δP 65 ppm)4h,4j suggesting 
comparable stereoelectronic properties. 
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X-ray analyses of 4 and 5 have been performed (Figure 3). The M−P, M−Cl(1) and M−Cl(2) (M = Ru 
or Rh) parameters for 4 and 5 are similar to those of analogous complexes with PTA.2b,4h,4j Morover, 
upon coordination of the phosphine 2a, there are minimal differences in the P−C and P−C−N metric 
parameters with respect to 1b, 2b or 3a. As seen previously for 1b, 2b or 3a, pairs of intramolecular 
N−H···N hydrogen-bonds are once again maintained upon complexation [4, N(1)···N(2) 2.894(3) Å, 
H(1A)···N(2) 2.22(3) Å, N(1)−H(1A)···N(2) 130(3)° and N(1)···N(3) 2.840(3) Å, H(1B)···N(3) 2.24(3) 
Å, N(1)−H(1B)···N(3) 128(3)°. 5, N(1)···N(2) 2.952(9) Å, H(1A)···N(2) 2.34 Å, N(1)−H(1A)···N(2) 
124° and N(1)···N(3) 2.851(8) Å, H(1B)···N(3) 2.18 Å, N(1)−H(1B)···N(3) 129°]. Additional weak H-
bonding interactions link molecules into dimer pairs (Supporting Information) and is a feature that has 
recently been observed in cationic dimeric RuII complexes of PTA.22 
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     (a)          (b) 
Figure 3. (a) ORTEP of the cation in 4. Selected bond lengths (Å) and angles (deg). Ru(1)−Cl(1) 
2.4064(7), Ru(1)−Cl(2) 2.4103(6), Ru(1)−P(1) 2.3293(6), Ru(1)−Cav 2.210(3), P(1)−C(1) 1.843(2), 
P(1)−C(9) 1.831(3), P(1)−C(10) 1.828(2). Cl(1)−Ru(1)−Cl(2) 88.00(2), Cl(1)−Ru(1)−P(1) 87.60(2), 
Cl(2)−Ru(1)−P(1) 83.75(2), P(1)−C(1)−N(1) 115.07(16), P(1)−C(9)−N(2) 110.35(16), P(1)−C(10)−N(3) 
111.74(16). (b) ORTEP of the cation in 5. Selected bond lengths (Å) and angles (deg). Rh(1)−Cl(1) 
2.406(2), Rh(1)−Cl(2) 2.424(2), Rh(1)−P(1) 2.2851(19), Rh(1)−Cav 2.188(8), P(1)−C(1) 1.834(7), 
P(1)−C(9) 1.836(8), P(1)−C(10) 1.830(7). Cl(1)−Rh(1)−Cl(2) 92.67(8), Cl(1)−Rh(1)−P(1) 88.85(7), 
Cl(2)−Rh(1)−P(1) 83.37(7), P(1)−C(1)−N(1) 115.4(5), P(1)−C(9)−N(2) 110.1(5), P(1)−C(10)−N(3) 
110.0(5). 
 
The electronic properties of 1a and 1b have been evaluated through preparation of the square-planar 
dicationic RhI carbonyl complexes 6a (88%) and 6b (93%) from Rh2(CO)4(µ-Cl)2 and the appropriate 
ligand. Both RhI compounds displayed poor solubility in common solvents preventing full 
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characterization. However FT−IR spectra of 6a and 6b were recorded as KBr pellets and showed, in 
each case, a single terminal carbonyl band at νCO 1979 cm−1. These findings suggest the electronic 
properties of 1a (R = CH2C6H5) and 1b (R = 4-CH2C6H4F) are similar despite the different para 
substituents. Although no direct comparisons between the FT−IR data for 6a/6b with the known neutral 
complexes trans-RhCl(CO)(L)2 [L = PTA, νCO 1963 cm−1 (chloroform); L = “lower-rim” trisubstituted 
analogues of PTA, νCO 1978−1987 cm−1 (chloroform)]2c,23 can be drawn, 1a and 1b can be viewed as 
possessing similar electron donating properties to this series of PTA ligands. 
 
Concluding Remarks 
In summary, we have shown how simple modification of the PTA core can be achieved in which non 
covalent interactions maintain the rigid cage structure in the solid state. Further studies are in progress 
and directed towards understanding the properties of this ligand family in aqueous and organic media, 
their coordination chemistry and potential catalytic/medicinal applications.  
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Table of Contents Synopsis − New intramolecular N−H···N stabilized cage phosphines and their 
selected complexes with RuII, RhI and RhIII have been synthesized and fully characterized. Comparisons 
with 1,3,5-triaza-7-phosphaadamantane (PTA) and its complexes revealed similar steric and electronic 
properties. 
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